Business news with perspective

Patagonia Gold celebrates first gold from its Calcatreu mine, a major operational win that ignites Argentina's Rio Negro economy amid deep-seated local dissent.

With healthcare drowning in a $1 trillion administrative burden, CAQH's rebrand to DataSpring is more than a name change—it's a high-stakes bet.

With expanded coverage for 52 million Americans, Tonix Pharmaceuticals' TONMYA® is not just a drug launch; it's a market disruption for chronic pain.

As GLP-1 drugs dominate, a UK biotech reveals a new drug that targets mitochondria, promising superior fat loss while preserving precious muscle mass.

Kymera Therapeutics' new lupus data isn't just about a drug. It's about a new strategy: erasing disease-causing proteins to build resilient value.

Mineralys Therapeutics' Lorundrostat shows promise in reducing heart failure risk, a breakthrough for millions struggling with uncontrolled hypertension.

With a new CMO known for getting drugs approved, Protego Biopharma is betting big on its novel approach to treating a devastating rare disease.

EQT appoints M&A mastermind Gustav Segerberg as CFO, signaling a doubling-down on its aggressive growth strategy. What does this mean for its future?

As Einride finalizes its public debut, a new partnership with Scan Sverige to electrify refrigerated freight signals a major breakthrough for the industry.

As FACE Coalition’s Melamoon tour lands in Halifax, it's clear this is more than a pitch contest. It’s a strategic move to dismantle systemic barriers.

A new warehouse near DFW is more than just logistics. It's a calculated move to combat costly aircraft downtime and redefine the global parts supply chain.

Fintech Nuvion's integration with Circle's payment network leverages USDC to tackle the high costs and delays of traditional cross-border business transactions.

At a key foreign policy forum, Minister Tim Hodgson is set to reframe Canada's global role, prioritizing energy and minerals in a calculated strategic pivot.

New data reveals a silent crisis as 3 in 5 HR pros consider quitting. We explore the tech debt and leadership gaps pushing them to the brink.

Cegid's acquisition of fintech unicorn Shine creates a massive financial platform for SMBs, leveraging AI to master Europe's coming wave of digital mandates.

Amai Proteins' sweelin® just got a major scientific boost. New clinical data in a top journal proves its metabolic safety, fast-tracking its commercial journey.

A new data-driven index is flipping the script on what makes a festival great, and the results are surprising. Here's why Europe is winning the culture war.

IBM's free SkillsBuild AI pathway aims to upskill the UK workforce from entry-level to C-suite, fueling national competitiveness and commercial AI adoption.

A new alliance is building a pay-per-use AI model for cars, backed by Beijing. It's a bid to redefine automotive value and create a trillion-level market.

With its new biomimetic DexHand and massive funding, TARS isn't just building a robot hand. It's aiming to bridge the gap between AI and the physical world.